Registration delays reduced for new medicines and consumer healthcare goods in Egypt
in EgyptTrade barrier summary
UK businesses seeking to register new drugs previously encountered significant delays when registering pharmaceutical products. 
Following 2 years of UK regulatory capacity building programmes, and engagement and an inward visit to the UK between the National Institute for Health and Care Excellence (NICE), the Medicines and Healthcare products Regulatory Agency (MHRA), the Department of Health & Social Care (DHSC) and Egyptian healthcare regulators, UK businesses have confirmed that registration times have improved from years to months. This has opened significant investment in the market.
Sectors affected
- Pharmaceuticals and biotechnology
- Consumer and retail
Resolved
Yes - March 2025
Date reported
3 November 2019
Last updated
30 October 2025
Public ID
PID-B76LQ9
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.